Signify Research Will be Attending the Digital Pathology and AI Congress Conference

Published: November 15, 2021

15th November 2021 – Signify Research will be attending the 8th Digital Pathology and AI Congress: Europe on the 1st and 2nd December 2021 to be held at the London Heathrow Marriott Hotel.

The Congress will provide you with a unique opportunity to take home cutting-edge strategies, analysis techniques, case study examples and methods to allow you to fully understand both the technology and accompanying informatics and image analysis tools and utilize digital pathology to its greatest potential.


  • Hear 55+ presentations exploring the latest advances and applications of digital pathology.
  • Learn how AI & machine learning is being applied to primary diagnosis & clinical research
  • Discover how the image-based information environment is transforming the laboratory.
  • Join an extended track featuring pharma and industry case studies.

How you will benefit

  • Hear about deep learning-based diagnostic tools
  • Get a pathologist’s view of real-life efficiency gains from using digital and computational pathology
  • Discover how the digitalization of glass slides coupled with deep learning-based artificial intelligence is advancing non-clinical pathology
  • Explore quality management and ISO 15189 compliance for digital whole slide imaging in histopathology laboratories
  • Examine the regulatory challenges of digital pathology and AI-based in vitro diagnostic medical devices
  • Build on existing partnerships and create new collaborations across industry & academia
  • Give a poster presentation
  • Attend the pre-event workshops

Our Analysts attending:

Steve Holloway – Principal Analyst

Steve has 10 years of experience in healthcare technology market intelligence, having served as
Senior Analyst at InMedica (part of IMS Research) and Associate Director for IHS Inc.’s Healthcare
Technology practice. Steve’s areas of expertise include Healthcare IT and Medical Imaging.


Imogen Fitt – Market Analyst

Imogen joined Signify in 2018 as part of the Healthcare IT team. She holds a 1st class Biomedical Sciences degree from the University of Warwick where her studies included molecular biology and pharmacology. Since joining the team Imogen has gained experience in market research studying the medical imaging software and hardware markets for both breast imaging and general X-ray.


To find out more information on the event itself please visit 

To discuss our attendance or to arrange a meeting with us at the event please contact us here.